Hemophilia is a general term for a group of rare bleeding disorders caused by congenital deficiency of certain coagulation factors, such as FVIII in hemophilia A and FIX in hemophilia B.1,2
An overview of hemophilia, including the different types of hemophilia, their causes, consequences and prevalence.
Refresh your knowledge about the symptoms and diagnosis of hemophilia and understand why early diagnosis and treatment may be important for your patients.
Understand the current treatment options and recommendations for patients with hemophilia A and B.
Pfizer is committed to supporting you and
your patients with hemophilia.
Learn more about the patient resources
available to support your patients.
Learn how the science underlying hemophilia is driving the development of new treatments.
Pfizer Products India Pvt. Ltd.,
The Capital-B wing, 1802, 18th Floor, Plot
No. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai, India.
FVIII, factor VIII; FIX, factor IX.
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.